Steven Cohen’s Neuphoria Therapeutics NEUP Stock Holding History

Steven Cohen’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-26,333	Closed	-$139K	–	2548
2024 Q3	$139K	Hold	26,333	–	–	﹤0.01%	1837
2024 Q2	$242K	Hold	26,333	–	–	﹤0.01%	1579
2024 Q1	$325K	Sell	26,333 -1,250	-5%	-$16.5K	﹤0.01%	1764
2023 Q4	$490K	Sell	27,583 -27,553	-50%	-$786K	﹤0.01%	1586
2023 Q3	$1.79M	Buy	55,136 +44,636	+425%	+$962K	0.01%	1169
2023 Q2	$277K	Sell	10,500 -167	-2%	-$4.63K	﹤0.01%	1373
2023 Q1	$333K	Hold	10,667	–	–	﹤0.01%	1340
2022 Q4	$595K	Buy	+10,667	New	+$926K	﹤0.01%	1129

Other funds holding NEUP

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's NEUP Position: Q4 2024 in Review

Steven Cohen sold out of Neuphoria Therapeutics (NEUP) in Q4 2024, closing a stake of 26,333 shares — an estimated $139K sold.

Steven Cohen first reported a position in NEUP in Q4 2022 and held it in 8 quarters. The position peaked at $1.79M in Q3 2023. 8 funds tracked by Wall St. Rank hold NEUP as of Q4 2024.

Steven Cohen reported no remaining Neuphoria Therapeutics position as of Q4 2024 after selling out during the quarter.
Steven Cohen sold 26,333 Neuphoria Therapeutics shares in Q4 2024, an estimated $139K.
Steven Cohen first reported a position in Neuphoria Therapeutics in Q4 2022 and held it in 8 quarters.
Steven Cohen's Neuphoria Therapeutics position peaked at $1.79M in Q3 2023.
8 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.